Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Many patients with the aggressive cancer diffuse large B-cell lymphoma (DLBCL) still respond poorly to treatment and suffer from relapsed or refractory disease. The identification of gene mutations that are responsible for the outgrowth of the relapsed tumor is crucial to understand...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Berendsen, Madeleine R., Stevens, Wendy B. C., van den Brand, Michiel, van Krieken, J. Han, Scheijen, Blanca
Formaat: Online Artikel Texto
Taal:English
Gepubliceerd in: MDPI 2020
Onderwerpen:
Review
Online toegang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Gelijkaardige items